Earnings summaries and quarterly performance for ASPEN AEROGELS.
Executive leadership at ASPEN AEROGELS.
Donald Young
Detailed
President and Chief Executive Officer
CEO
CW
Corby Whitaker
Detailed
Senior Vice President, Sales and Marketing
GL
Gregg Landes
Detailed
Senior Vice President, Operations and Strategic Development
KS
Keith Schilling
Detailed
Senior Vice President, Technology
RR
Ricardo Rodriguez
Detailed
Chief Financial Officer and Treasurer
SP
Stephanie Pittman
Detailed
Chief Human Resources Officer
VJ
Virginia Johnson
Detailed
Chief Legal Officer, General Counsel and Corporate Secretary
Board of directors at ASPEN AEROGELS.
Research analysts who have asked questions during ASPEN AEROGELS earnings calls.
CR
Colin Rusch
Oppenheimer & Co. Inc.
6 questions for ASPN
Also covers: AEVA, ALB, AMPX +25 more
Eric Stine
Craig-Hallum Capital Group LLC
5 questions for ASPN
Also covers: ALTO, AMRC, AMSC +19 more
George Gianarikas
Canaccord Genuity
4 questions for ASPN
Also covers: AEVA, AIRJ, AMRC +21 more
Ryan Pfingst
B. Riley Securities
4 questions for ASPN
Also covers: AMPX, AMRC, EOSE +8 more
CM
Chip Moore
EF Hutton
3 questions for ASPN
Also covers: AMPX, CMT, ENS +3 more
JO
Jeffrey Osborne
TD Cowen
2 questions for ASPN
Also covers: AUR, BLDP, CRNC +14 more
LH
Leanne Hayden
Canaccord Genuity Group Inc.
2 questions for ASPN
Also covers: AUR, LYTS, MP +1 more
TP
Thomas Patrick Curran
Seaport Research Partners
2 questions for ASPN
Also covers: EOSE, HP, LBRT +1 more
AP
Alex Potter
Piper Sandler & Co.
1 question for ASPN
Also covers: BWA, CVNA, LILM +2 more
DA
David Anderson
Barclays PLC
1 question for ASPN
Also covers: BKR, CHX, FTI +8 more
IM
Itay Michaeli
TD Cowen
1 question for ASPN
Also covers: APTV, AUR, AXL +13 more
J. David Anderson
Barclays
1 question for ASPN
Also covers: BKR, FTI, HAL +7 more
TC
Tom Curran
Seaport Research Partners
1 question for ASPN
Also covers: HP, LBRT
Recent press releases and 8-K filings for ASPN.
Aspen Aerogels Reports Q4 and Full Year 2025 Results, Provides Q1 2026 Outlook, and Initiates Strategic Review
ASPN
Earnings
Guidance Update
New Projects/Investments
- Aspen Aerogels reported Q4 2025 revenue of $41.3 million, a GAAP net loss of $72.9 million, and negative $18 million in adjusted EBITDA. For the full year 2025, revenue totaled $271.1 million and adjusted EBITDA was $2.9 million.
- The company ended 2025 with $158.6 million in cash and cash equivalents and anticipates receiving a $38 million payment from General Motors in March 2026.
- For Q1 2026, total revenue is projected between $35 million and $40 million, with anticipated adjusted EBITDA between negative $13 million and negative $10 million. This is expected to be the lowest revenue quarter of the year, with sequential growth anticipated thereafter.
- Aspen Aerogels is undertaking a strategic review to maximize shareholder value and has significantly reduced its adjusted EBITDA breakeven level from $330 million in 2024 to $270 million in 2025, targeting $175 million by 2027.
- The Energy Industrial segment is poised for 20% growth in 2026, and the company is developing a Battery Energy Storage Systems (BESS) segment with anticipated revenue beginning in 2026. The European EV market pipeline represents approximately $220 million for 2027 launches and $450 million for 2028.
3 days ago
Aspen Aerogels Reports Q4 and Full Year 2025 Results, Provides Q1 2026 Outlook, and Initiates Strategic Review
ASPN
Earnings
Guidance Update
New Projects/Investments
- Aspen Aerogels reported Q4 2025 revenue of $41.3 million and a GAAP net loss of $72.9 million, with full-year 2025 revenue totaling $271.1 million and adjusted EBITDA of $2.9 million.
- For Q1 2026, the company anticipates total revenue between $35 million and $40 million and adjusted EBITDA between negative $13 million and negative $10 million, expecting this to be the lowest revenue quarter of the year.
- The company ended 2025 with $158.6 million in cash and cash equivalents and expects a $38 million payment from General Motors in March 2026, strengthening its liquidity position.
- Aspen Aerogels is targeting 20% growth in its Energy Industrial segment for 2026, aiming to scale it into a $200 million high-margin segment, and is actively developing a new Battery Energy Storage Systems (BESS) segment with anticipated revenue starting in 2026.
- The company has significantly reduced its adjusted EBITDA breakeven level from $330 million in 2024 to $270 million in 2025, with a target of $175 million by 2027, and has initiated a strategic review to maximize shareholder value.
3 days ago
Aspen Aerogels Reports Q4 and Full Year 2025 Results, Provides Q1 2026 Outlook, and Initiates Strategic Review
ASPN
Earnings
Guidance Update
New Projects/Investments
- Aspen Aerogels reported Q4 2025 revenue of $41.3 million and a GAAP net loss of $72.9 million, with full-year 2025 revenue reaching $271.1 million and adjusted EBITDA of $2.9 million.
- For Q1 2026, revenue is guided between $35 million and $40 million, with adjusted EBITDA expected to be negative $13 million to negative $10 million, anticipating Q1 to be the lowest revenue quarter of the year.
- The company expects 20% revenue growth in its Energy Industrial segment for 2026 and is actively developing a new Battery Energy Storage Systems (BESS) segment, with revenue anticipated to begin in 2026.
- Aspen Aerogels ended 2025 with approximately $159 million in cash and expects a $38 million payment from GM in March 2026, further strengthening its balance sheet.
- A strategic review process has been initiated to explore opportunities to maximize long-term shareholder value and accelerate growth, conducted from a position of financial strength.
3 days ago
Aspen Aerogels Reports Q4 & FY 2025 Financial Results and Provides 2026 Outlook
ASPN
Earnings
Guidance Update
New Projects/Investments
- Aspen Aerogels reported Q4 2025 revenues of $41.3 million and a net loss of $(72.9) million, contributing to full-year 2025 revenues of $271.1 million and a net loss of $(389.6) million, which included a $291.2 million impairment charge related to the Statesboro Plant.
- For Q1 2026, the company anticipates revenues between $35 million and $40 million and an Adjusted EBITDA loss between $(10) million and $(13) million, with full-year 2026 CAPEX projected to be less than $10 million.
- The company concluded 2025 with a cash position of $158.6 million and expects a $37.6 million GM commercial settlement in Q1 2026, having also implemented a $75 million structural fixed cost reduction.
- Aspen Aerogels is targeting 20% revenue growth in Energy Industrial in 2026 and identifies a potential $220 million opportunity in 2027, growing to over $450 million in 2028, from awarded and quoted European Thermal Barrier programs.
3 days ago
Aspen Aerogels Reports Q4 and Full Year 2025 Financial Results, Initiates Strategic Review
ASPN
Earnings
Guidance Update
Demand Weakening
- Aspen Aerogels reported a net loss of $389.6 million for the full year 2025, including a $291.2 million impairment charge, compared to a net income of $13.4 million in the prior year.
- Total revenue for full year 2025 decreased to $271.1 million from $452.7 million in the prior year, primarily due to a significant reduction in thermal barrier segment customer demand.
- The company ended 2025 with $158.6 million in cash and expects to receive a $37.6 million commercial settlement payment from General Motors in Q1 2026.
- Aspen Aerogels has initiated a strategic review to evaluate opportunities for strengthening its long-term competitive position and optimizing its capital structure.
- For Q1 2026, the company forecasts revenue between $35 million and $40 million and a net loss between $20 million and $23 million.
3 days ago
Aspen Aerogels Reports Q4 and Full Year 2025 Financial Results and Initiates Strategic Review
ASPN
Earnings
Guidance Update
Demand Weakening
- Aspen Aerogels reported total revenue of $41.3 million for Q4 2025 and $271.1 million for full year 2025, a significant decrease from the prior year, resulting in a net loss of $72.9 million for Q4 2025 and $389.6 million for full year 2025.
- The company ended 2025 with a cash balance of $158.6 million and anticipates a $37.6 million GM commercial settlement payment in Q1 2026.
- Aspen Aerogels has initiated a strategic review to evaluate opportunities to strengthen its long-term competitive positioning and optimize its capital structure.
- For Q1 2026, the company expects revenue to range between $35 million and $40 million and a net loss between $20 million and $23 million.
3 days ago
Aspen Aerogels Amends MidCap Credit Facility
ASPN
Debt Issuance
Guidance Update
- Aspen Aerogels, Inc. announced an amendment to its existing Credit, Security and Guaranty Agreement with MidCap Financial.
- The amendment is designed to enhance Aspen's financial position and provides additional flexibility by updating the company's financial covenant framework.
- Grant Thoele, Aspen's Chief Financial Officer & Treasurer, stated that the company's liquidity outlook is trending ahead of expectations, driven by operational efficiencies, working capital improvements, and prudent capital spending, which will support the execution of its 2026 strategy.
Dec 17, 2025, 11:30 PM
Aspen Aerogels Reports Q3 2025 Results and Updates Outlook Amid EV Market Headwinds
ASPN
Earnings
Guidance Update
Demand Weakening
- Aspen Aerogels reported Q3 2025 revenue of $73 million and adjusted EBITDA of $6.3 million. The company provided Q4 2025 revenue guidance of $40 million to $50 million and adjusted EBITDA guidance of negative $14 million to negative $6 million, leading to a full-year 2025 revenue outlook of $270 million to $280 million and adjusted EBITDA of $7 million to $15 million.
- The North American EV market is experiencing significant headwinds, with GM recalibrating production due to regulatory shifts and softer consumer demand. Despite this, Aspen secured a new European OEM design award with potential to ramp in 2027 and anticipates ACC (a European customer) to ramp battery cell production in 2026, with European OEMs potentially contributing $10 million to $15 million in 2026 and over $150 million in 2027 at full volumes.
- The energy industrial segment is stabilizing and expected to grow in 2026, with subsea project revenue potentially exceeding $80 million over the next three years (including $15 million to $20 million in 2026) and a long-term trajectory towards a $200 million business. Additionally, new opportunities are emerging in battery energy storage systems (BESS), leveraging Pyrothin thermal barrier technology.
- Grant Fairley assumed the role of CFO effective October 1st, and Glenn Deegan was appointed Chief Administrative Officer. The company aims for adjusted EBITDA break-even at approximately $200 million of annual revenue, with an operating expense run rate of $20 million to $22 million and expects to drop $0.50 to $0.60 to the bottom line on every dollar of additional revenue above break-even.
Nov 6, 2025, 1:30 PM
Aspen Announces Q3 2025 Earnings and Full-Year Outlook
ASPN
Earnings
Guidance Update
Demand Weakening
- Aspen reported Q3 2025 revenues of $73.0 million, a net loss of $(6.3) million, and Adjusted EBITDA of $6.3 million.
- The company provided a full-year 2025 revenue outlook of $270-280 million and Adjusted EBITDA of $7-15 million.
- The US EV market reset is driving lower near-term volumes, while Energy Industrial revenues increased 7% quarter-over-quarter.
- Aspen is targeting break-even EBITDA at approximately $200 million of revenue and less than $10 million in CAPEX for 2026, supported by a $150 million awarded revenue contract from a major European OEM.
Nov 6, 2025, 1:30 PM
Aspen Aerogels Reports Q3 2025 Financial Results and Updates Full-Year Outlook
ASPN
Earnings
Guidance Update
Demand Weakening
- Aspen Aerogels, Inc. reported Q3 2025 revenue of $73.0 million, a decrease from $117.3 million in Q3 2024, with a net loss of $6.3 million and Adjusted EBITDA of $6.3 million.
- The company updated its full-year 2025 financial outlook, revising revenue to $270 – $280 million and Adjusted EBITDA to $7 – $15 million, primarily reflecting lower near-term EV production in North America.
- Business highlights include securing a PyroThin® award from a major EU OEM with production slated for 2027, and anticipating LNG and Subsea project opportunities to drive Energy Industrial growth in 2026.
Nov 6, 2025, 11:30 AM
Quarterly earnings call transcripts for ASPEN AEROGELS.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more